RxDoctor Payments Data

Luis Romero Cortez, MD

Family Medicine · Zionsville, INNPI 1053574491

Payments from drug & device makers

$567in general payments, 2019–2025

Across 40 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$191
  • AstraZeneca$125
  • Sanofi-aventis U.S. LLC$55
  • Amgen$46
  • Lilly USA, LLC$43
  • Amarin Pharma, Inc.$26
  • plus $82 from 5 others

What the payments were for

  • Food & beverage$56199%
  • Education$61%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$567 in reported general payments places this provider in the 50th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$57,997
Medicare patients
158
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$81,422
MounjaroTirzepatide54$79,191
JardianceEmpagliflozin56$73,064
TrulicityDulaglutide48$61,313
Repatha SureclickEvolocumab41$40,511
EliquisApixaban21$29,431
JanuviaSitagliptin Phosphate17$27,802
LinzessLinaclotide31$18,353
XareltoRivaroxaban15$11,678
Lubiprostone25$4,507
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,773
Atorvastatin Calcium334$2,451
Sucralfate13$2,326
Novolog FlexpenInsulin Aspart14$1,901
Levothyroxine Sodium205$1,769

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$43$140,505102 claims
Novo NordiskOzempic$191$81,42259 claims
Boehringer IngelheimJardiance$13$73,06456 claims
PfizerEliquis$25$29,43121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Zionsville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →